Standard Biotools (LAB) Change in Cash (2010 - 2026)

Standard Biotools (LAB) has reported Change in Cash for 17 consecutive years, with $4.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Cash fell 45.0% year-over-year to $4.3 million in Q2 2026; TTM through Jun 2026 was $110.9 million, a 200.93% increase from a year earlier, with the FY2025 full-year figure at -$45.5 million, down 139.14% from the prior year.
• Change in Cash was $4.3 million for Q2 2026 at Standard Biotools, down from $144.6 million in the prior quarter.
• Over five years, Change in Cash peaked at $235.8 million in Q1 2024 and troughed at -$62.6 million in Q3 2023.
• A 5-year average of $13.5 million and a median of -$3.6 million in 2022 frame the typical range for Change in Cash.
• The widest YoY moves for Change in Cash: up 1997.52% in 2023, down 342.37% in 2023.
• Over 5 years, Change in Cash stood at $21.1 million in 2022, then tumbled by 232.41% to -$28.0 million in 2023, then plunged by 54.27% to -$43.1 million in 2024, then surged by 79.8% to -$8.7 million in 2025, then soared by 148.83% to $4.3 million in 2026.
• The last three Change in Cash figures came in at $4.3 million (Q2 2026), $144.6 million (Q1 2026), and -$8.7 million (Q4 2025), per Business Quant data.